Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of MMRV Vaccine Regimens in Healthy Children
NCT00969436Phase 3Completed
- Sponsor
- GSK
- Start
- Nov 2009
- Primary completion
- Feb 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of GSK208136 in measles, mumps, rubella, varicella (VZV), sponsored by GSK. Started Nov 2009; status: completed.
02
Drugs
GSK208136
03
Conditions
measlesmumpsrubellavaricella (VZV)
Beyond the preview
Go deeper on NCT00969436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00969436.